Evento
Epidermal growth factor receptor (EGFR) activation induces the expression of multidrug resistance associated protein 4 (MRP4/ABCC4) in a pancreatic cancer human cell line
Lago, Rodrigo; Barosso, Ismael Ricardo
; Sahores, Ana
; Imperiale, Julieta; Manautou, José E.; Davio, Carlos Alberto
; Ghanem, Carolina Inés
Tipo del evento:
Reunión
Nombre del evento:
Reunión Anual de la Sociedad Argentina de Fisiología
Fecha del evento:
10/10/2019
Institución Organizadora:
Sociedad Argentina de Fisiología;
Título de la revista:
Physiological Mini Reviews
Editorial:
Sociedad Argentina de Fisiología
ISSN:
1669-5410
Idioma:
Inglés
Clasificación temática:
Resumen
Pancreatic ductal adenocarcinoma (PDAC) is the most frequent type of pancreatic cancer and has one of the worse prognosis. The poor overall survival is associated with the overexpression of epidermal growth factor receptor (EGFR), a known member of the ErbB family of receptor tyrosine kinases and multidrug resistance associated protein 4 (MRP4/ABCC4). Our previous results show that high levels MRP4 are associated with increase in tumor cell proliferation, metastatic invasion and up-regulation of EGFR protein levels in PDACs cell lines. The aim of our study was to evaluate the regulation of MRP4 by EGFR activation in a pancreatic cancer cell model. To accomplish our objective, we treated the pancreatic cancer cell line BxPC-3 with EGF (0.1ng/ul). EGFR activation was confirmed by ERK phosphorylation at 5, 10, 20, 30, and 40 min after EGF treatment. MRP4 protein expression was evaluated by western blot using whole cell extracts following incubation with EGF for 0, 24 and 48 h, using histone as loading control. MRP4 expression levels were also assessed 48 h after treatment with EGF alone or in combination with the EGFR inhibitor CL 387-785 (1µM). Our results confirm that EGFR is quickly activated upon incubation with EGF, as evidenced by a 4-fold increase in the pERK/total ERK ratio detected (P<0.001) at 5 min and normalized at 40 min. Maximal induction of MRP4 expression (86%, P<0.001) was observed in cells treated with EGF for 48 h. Furthermore, EGF-mediated MRP4 induction was abolished by co-treatment with CL387-785 (P<0.05), while its expression does not change by treatment with this EGFR inhibitor alone. These data demonstrate that EGFR activation produces increments in MRP4 protein levels in a PDAC cell line. In summary, it is possible that MRP4 and EGFR, both PDAC poor prognosis markers, are co-regulated by a positive feed-back which ultimately enhances their effect upon each other.
Archivos asociados
Licencia
Identificadores
Colecciones
Eventos(ININFA)
Eventos de INST.DE INVEST.FARMACOLOGICAS (I)
Eventos de INST.DE INVEST.FARMACOLOGICAS (I)
Citación
Epidermal growth factor receptor (EGFR) activation induces the expression of multidrug resistance associated protein 4 (MRP4/ABCC4) in a pancreatic cancer human cell line; Reunión Anual de la Sociedad Argentina de Fisiología; Rosario; Argentina; 2019; 1-1
Compartir